Agomelatine efficacy in treatment resistant obsessive-compulsive disorder: A randomized controlled trial.

This study, while not confirming superior efficacy compared to placebo, underscores the need for continued investigation into agomelatine's potential for treating specific subgroups of OCD patients, underscoring the need for more comprehensive and well-controlled trials in the future.